CEYLON - CONTINUING PRACTICE OF CONTRACEPTION BY ACCEPTORS OF ORAL-CONTRACEPTIVES AND INTRAUTERINE-DEVICES IN A FIELD PROGRAM

被引：0
|
作者：
WRIGHT, NH [1 ]
PERERA, T [1 ]
机构：
[1] MINIST HLTH, FAMILY PLANNING BUR, CEYLON, COLUMBIA
来源：
BULLETIN OF THE WORLD HEALTH ORGANIZATION | 1973年 / 48卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
引用
收藏
页码：639 / 647
页数：9
相关论文
共 20 条
  • [1] COPPER LEVELS IN WOMEN USING INTRAUTERINE-DEVICES OR ORAL-CONTRACEPTIVES
    HEFNAWI, F
    KANDIL, O
    ASKALANI, H
    ZAKI, K
    NASR, F
    MOUSA, M
    [J]. FERTILITY AND STERILITY, 1974, 25 (07) : 556 - 561
  • [2] LOW-DOSE ORAL-CONTRACEPTIVES AND COAGULATION - COMPARISON WITH HIGH-DOSE ORAL-CONTRACEPTIVES AND INTRAUTERINE-DEVICES
    NOTELOVITZ, M
    KITCHENS, C
    WARE, MD
    COONE, L
    MCKENZIE, L
    [J]. CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 1983, 33 (02): : 207 - 213
  • [3] SERUM-LIPID VARIATIONS IN WOMEN ON COPPER INTRAUTERINE-DEVICES, TRIPHASIC ORAL-CONTRACEPTIVES AND MONTHLY INJECTABLE CONTRACEPTIVES
    KESSERU, E
    ALBORNOZ, H
    DIAZ, M
    SOCOLSKY, R
    [J]. CONTRACEPTION, 1991, 44 (03) : 235 - 244
  • [4] RISK OF CERVICAL DYSPLASIA IN USERS OF ORAL-CONTRACEPTIVES, INTRAUTERINE-DEVICES OR DEPOT-MEDROXYPROGESTERONE ACETATE
    LIGGINS, G
    MACMAHON, B
    OLANOFF, LS
    REMINGTON, RD
    SEDDON, RJ
    SHEARMAN, RP
    WIED, GL
    TILLOTT, M
    FITZGERALD, N
    DRAKE, M
    YAMAUCHI, K
    HAWKINS, CM
    LEE, JG
    TONG, DM
    PENHALLEGON, RA
    TILLS, G
    AITKEN, L
    CAMERON, J
    GOOSTREY, SA
    BANDSTRA, B
    [J]. CONTRACEPTION, 1994, 50 (05) : 431 - 441
  • [5] COMPARISON OF INTRAUTERINE CONTRACEPTIVE DEVICES AND ORAL-CONTRACEPTIVES IN NULLIPARA
    EDWARDS, LE
    MCCREARY, MK
    HAKANSON, EY
    [J]. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1974, 120 (04) : 470 - 475
  • [6] PLASMA PROLACTIN LEVELS AND CONTRACEPTION - ORAL-CONTRACEPTIVES AND INTRA-UTERINE DEVICES
    SPELLACY, WN
    MAHAN, CS
    BUHI, WC
    DUMBAUGH, VS
    [J]. CONTRACEPTION, 1978, 17 (01) : 71 - 77
  • [7] NEW DEVELOPMENTS IN ORAL, INJECTABLE AND IMPLANTABLE CONTRACEPTIVES, VAGINAL RINGS AND INTRAUTERINE-DEVICES - A REVIEW
    DICZFALUSY, E
    [J]. CONTRACEPTION, 1986, 33 (01) : 7 - 22
  • [8] EFFECT OF INTRAUTERINE DEVICES, ORAL-CONTRACEPTIVES, ESTROGENS, AND PROGESTOGENS ON BLOOD-PRESSURE
    SPELLACY, WN
    BIRK, SA
    [J]. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1972, 112 (07) : 912 - &
  • [9] EFFECTS OF ESTROGENS, PROGESTOGEN, ORAL-CONTRACEPTIVES, AND INTRAUTERINE DEVICES ON FASTING TRIGLYCERIDE AND INSULIN LEVELS
    SPELLACY, WN
    BUHI, WC
    BIRK, SA
    CABAL, R
    [J]. FERTILITY AND STERILITY, 1973, 24 (03) : 178 - 184
  • [10] New developments and practice guidelines: Oral contraceptives and intrauterine devices - Introduction
    Mishell, DR
    [J]. CONTRACEPTION, 1998, 58 (03) : 7S - 8S
12